Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics | 500 | 2023q3 | |||||||||
Eurasia Mining | 102 | 2023q2 | |||||||||
Hyliion Holdings | 445 | 2024q2 | |||||||||
BioXcel Therapeutics | 17 | 2022 | |||||||||
Denali Therapeutics | 3,340 | 2024q2 | |||||||||
Beyond Air | 50 | 2024q1 | |||||||||
Inovio Pharmaceuticals | 2,526 | 2021 | |||||||||
IGM Biosciences | 827 | 2023q3 | |||||||||
Lucid Group | 4,580 | 2021 | |||||||||
Virgin Galactic Holdings | 342 | 2023 | |||||||||
Shattuck Labs | 401 | 2023q3 | |||||||||
BridgeBio Pharma, Inc | 4,631 | 2023 | |||||||||
uniQure | 223 | 2023q3 | |||||||||
Sage Therapeutics | 799 | 2023q3 | |||||||||
Praxis Precision Medicine... | 10,011 | 2023q3 | |||||||||
GeoVax Labs | 158 | 2021 | |||||||||
Pliant Therapeutics | 851 | 2023q3 | |||||||||
Vaxart | 104 | 2023q3 | |||||||||
Anterix | 640 | 2022 | |||||||||
Marker Therapeutics | 332 | 2021 |